 |
Medicines
in development 2009 |
| |
Biopharmaceutical Companies Developing Record
183 Medicines to Treat Diabetes and Related Conditions (Pharmaceutical
Research and Manufacturers of America) |
| |
|
|
Diabetes
drugs compared |
| |
This thorough study compared the risk levels
associated with different medications for type 2 diabetes, and
did not compare the different drugs versus no treatment. For this
reason people should not stop taking their medication based on
this study, as taking no medication is likely to be more dangerous
(NHS Choices) |
| |
|
|
An
Economic Tsunami: The Cost of Diabetes in Canada |
| |
Diabetes is not only a personal crisis for the
people living with the disease, it is also a tremendous financial
burden for the Canadian healthcare system and society as a whole
- Full report (Canadian Diabetes Association) |
| |
|
|
House
accepts resolution for diabetes funding |
| |
The House of Representatives passed, by a voice
vote, H. Res. 35, a resolution urging increased federal funding
for type 1 diabetes research (Examiner, USA) |
| |
|
|
Gestational
glucose intolerance predicted likelihood of postpartum metabolic
syndrome |
| |
Even mild glucose intolerance during pregnancy
appears to predict an increased likelihood for metabolic syndrome
at three months postpartum, according to data published online
in The Journal of Clinical Endocrinology and Metabolism (Endocrine Today) |
| |
|
|
Insulin
Resistance and Metabolic Syndrome in the Pediatric Population |
| |
This review summarizes current research regarding
the pathophysiology of insulin resistance and how this may contribute
to specific abnormalities seen in children and adolescents with
the metabolic syndrome (Mary Ann Liebert, Inc) |
| |
|
|
Does
intensive glucose control reduce cardiovascular events and mortality
in patients with type 2 diabetes mellitus? |
| |
In patients with type 2 diabetes mellitus, intensive
glucose control reduced some cardiovascular events but did not
change overall mortality (Evidence-Based Medicine) |
| |
|
|
Association
Between Adherence and Glycemic Control in Pediatric Type 1 Diabetes |
| |
This meta-analysis supports the adherence-glycemic
control link in pediatric type 1 diabetes. The weaker post-DCCT
association suggests that the approach to intensive diabetes management
has shortcomings (Pediatrics) |
| |
|
|
Gene
mutation for obesity 'rare' |
| |
The number of very severely obese children with
the genetic deletions on part of chromosome 16 were rare. It should
not, therefore, be assumed that all severely obese people have
this genetic mutation. It is likely that the majority of obesity
is related to environmental causes (NHS Choices) |
| |
|
|
Novo
Nordisk starts trials for oral insulin drug |
| |
Novo Nordisk has initiated its first Phase I
trial with an oral insulin analogue, called NN1952, which it hopes
could one day provide an alternative to daily injections for diabeties
patients (PharmaTimes) |
| |
|
|
Real-time
detection of nocturnal hypoglycemic episodes using a novel non-invasive
hypoglycemia monitor |
| |
For hypoglycemic episodes at night, their heart
rates increased and corrected QT intervals increased significantly
(PubMed) |
| |
|
|
Lilly
Announces the First 300-unit Vial of Insulin |
| |
The new smaller vial - for Lilly's Humalog(R)
(insulin lispro injection [rDNA origin]) and Humulin(R) R-U100
(regular insulin human injection, USP [rDNA origin)]) - is intended
to provide hospitals more flexibility when evaluating insulin storage,
delivery and distribution options (Lilly) |
| |
|
|
Aerobic
exercise in obese diabetic patients with chronic kidney disease |
| |
Exercise training in obese diabetic patients
with CKD is feasible and results in a demonstrable training effect
- a randomized and controlled pilot study (Cardiovascular Diabetology) |
| |
|
|
Steroid
therapy may provide stable, durable benefits to five years in
patients with diabetic macular edema |
| |
Intravitreal steroid therapy proved durable
out to five years in patients treated for vision loss secondary
to diabetic macular edema and benefited patients who were initially
treated with placebo in the first two years of a study (Endocrine
Today) |
| |
|
|
Parents
Receptive to Sending Blood Sugar Readings Via Text |
| |
A survey by the Center for Connected Health
found more than half of parents of children with diabetes were
interested in a glucometer service that would use cellular phones
to collect and transmit a child's blood sugar readings to a doctor
(American Diabetes Association) |
| |
|
